In brief
Chinese health‑ingredient companies highlighted at SupplySide Global 2026 a strategic shift towards finished, branded goods, with firms such as Ganoherb and Changsha Huir outlining plans for U.S. processing facilities and deeper market penetration. The event marked a record high in Chinese participation, underscoring the sector’s growing global influence. Analysts note that while China supplies about 80 percent of raw materials for the dietary supplement industry, its move up the value chain could reshape supply dynamics.
At the conclusion of SupplySide Global 2026 on Friday at Mandalay Bay, Las Vegas, more than 1,600 exhibitors and more than 20,000 industry professionals gathered, including a record high of nearly 600 Chinese companies, the Xinhua news agency reported. The focus of the Chinese presence was not only raw material supply but also the development of higher‑value finished products and the building of proprietary brands.
Ganoherb Group, a major producer of organic lingzhi—also known as the reishi mushroom—in China announced its intent to shift from OEM services and raw material supply to branded finished goods in the United States. Li Ye, the company’s president and founder, told Xinhua that Ganoherb plans to intensify its branding efforts in the U.S. market, leveraging China’s deep traditions in lingzhi cultivation. The company showcased reishi mushroom coffee and tea made with concentrated extracts at the expo, arguing that intensity of competition on raw‑material pricing was prompting the pivot.
Similarly, Changsha Huir Biological‑Tech Co., Ltd., based in Hunan Province, also highlighted its ambition to move up the value chain. General manager Yuan Zhi said the company will build a U.S. processing facility to manufacture finished products for global distribution. The facility, he explained, would allow the firm to extend beyond ingredient supply and create a more integrated supply chain, drawing on China’s diverse raw‑material sources and increasingly automated, energy‑efficient production equipment.
The rise in Chinese participation, nearly 600 exhibitors against a record, underscored the critical role of Chinese factories and suppliers in the dietary supplement industry. Loren Israelsen, president of the United Natural Products Alliance, told Xinhua that China “supplies roughly 80 percent of the industry's raw materials.” He emphasized that “having good Chinese suppliers is fundamental to the success of the American marketplace and to sustaining a high standard of product quality.”
Experts note that the pivot towards finished, branded products could lead to tighter quality control and distinctive market positioning for Chinese firms. Analysts observe that the move further integrates Chinese manufacturing into the downstream stages of the supply chain, potentially altering the competitive landscape in North America and beyond. The ability to control brand perception might also allow Chinese companies to capture higher margins than when operating solely as raw‑material suppliers.
However, questions remain about the practical challenges these firms will face in establishing U.S. processing plants. Regulatory compliance, ingredient certification, and consumer acceptance are all critical factors that could affect the speed and success of market entry. Additionally, the shift might prompt U.S. manufacturers to reevaluate their sourcing strategies, potentially leading to diversification of suppliers or investment in domestic processing capabilities.
Industry observers as well as market analysts are watching the subsequent weeks for signs of the companies’ concrete progress on establishing U.S. facilities, building local partnerships, and launching branded lines. If successful, the shift could signal a broader realignment of the global dietary supplement supply chain, with China moving beyond raw materials into full product development and brand building.
